COVID-19 might be a trigger for new ulcerative colitis for some people. It may also be a trigger for symptom flare-ups for people previously diagnosed with UC. COVID-19 is a respiratory illness ...

The search for effective therapies in ulcerative colitis, a chronic inflammatory condition affecting the colon and rectum ...

In a new report this week, the FDA highlighted several serious adverse events and deaths associated with the drug Librela.

The discovery may help define how to treat patients with severe ... Early Life Exposure to Broccoli Sprouts Protects Against Colitis in Inflammatory Bowel Disease Nov. 9, 2023 — High fiber ...

Ulcerative colitis (UC) symptoms such as diarrhea and ... inflammation Malnutrition can also reduce the effectiveness of treatment for UC. “When protein loss and malnutrition occur, many of ...

The FDA's Center for Veterinary Medicine posted a letter alerting veterinarians of adverse health effects in dogs from ...

We talked to veterinarians and professional dog trainers to find the absolute best dog treats for any kind of dog. Here are ...

Crohn's disease and ulcerative colitis are idiopathic ... patients for whom the natural history of disease and response to treatment are predictable. The most widely held hypothesis on the ...

Recalled dog treats sold online and in stores in 19 U.S. states have been assigned the highest risk level by the U.S. Food and Drug Administration (FDA). A "Class I" recall means "there is a ...

With the submission of a supplemental biologics license (sBLA) application for golimumab (Simponi), Johnson & Johnson is seeking expanded approval of the anti-TNF biologic to include pediatric ...

Ulcerative colitis can be a challenging disease to treat especially in younger populations, reinforcing the need for additional treatment options. Developed by Johnson & Johnson, SIMPONI is an ...

The agency recommended that the maker of Librela update its label to reflect the possibility of more serious adverse ...